About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
On January 13, PhRMA’s President and CEO Steve Ubl participated in an Endpoints panel, “Healthcare Policy Under the New Administration,” as part of their coverage of the J.P. Morgan Healthcare Conference. During the interview, Steve discussed how the new administration can get rid of inefficiencies in the health care system, address the role PBMs and the 340B program play in driving up health care costs, and potential changes to the IRA that could come from the new administration and Congress, including addressing the pill penalty.
When:
Monday, January 13, 2025
Speakers:
- Dina Radenkovic, Co-Founder & CEO, Gameto
- Stephen J. Ubl, President & CEO, PhRMA
- Juliette Cubanski, Deputy Director, Program on Medicare Policy, KFF
- Katherine Andersen, Head of Life Science & Healthcare, HSBC Innovation Banking US
- Meena Seshamani, Former Deputy Administrator & Director, CMS
- Drew Armstrong, Executive Editor, Endpoints News (Moderator)